Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Catheter Cardiovasc Interv. 2022 Feb;99(2):286-292. doi: 10.1002/ccd.30076. Epub 2022 Jan 12.
The Index of Microcirculatory Resistance (IMR), measured with a pressure-thermistor tipped coronary guidewire has been established as a gold standard for coronary microvascular assessment. Angiography-based IMR (angio-IMR) is a novel method to derive IMR without intracoronary instrumentation or the need for adenosine.
PubMed and Embase databases were systemically searched in November 2021 for studies that measured angio-IMR. The primary outcomes were pooled sensitivity and specificity as well as the area under the curve (AUC) of the summary receiver operating characteristic curve using IMR as a reference standard.
A total of 129 records were initially identified and 8 studies were included in the final analysis. Overall, 1653 lesions were included in this study, of which 733 were in patients presenting with ST-segment elevation myocardial infarction. Angio-IMR yielded high diagnostic performance predicting wire-based IMR with pooled sensitivity = 0.81 (95% confidence interval: 0.76, 0.85), specificity = 0.80 (0.72, 0.86), and AUC = 0.86 (0.82, 0.88), which was similar irrespective of patient presentation. When the clinical outcome was compared between high versus low angio-IMR in patients presenting with myocardial infarction, high angio-IMR predicted an increased risk of major adverse cardiac events (MACE).
Our study found that coronary angio-IMR has relatively high diagnostic performance as well as prognostic values predicting MACE, supporting its use in clinical practice.
使用压力热敏尖端冠状动脉导丝测量的微血管阻力指数(IMR)已被确立为冠状动脉微血管评估的金标准。基于血管造影的 IMR(angio-IMR)是一种新的方法,无需进行冠状动脉内仪器操作或使用腺苷即可得出 IMR 值。
我们于 2021 年 11 月系统地在 PubMed 和 Embase 数据库中搜索了测量 angio-IMR 的研究。主要结局指标是汇总受试者工作特征曲线下的曲线面积(AUC)以及作为参考标准的 IMR 的敏感性和特异性。
最初共确定了 129 条记录,最终有 8 项研究被纳入最终分析。共有 1653 处病变纳入本研究,其中 733 处病变发生在出现 ST 段抬高型心肌梗死的患者中。angio-IMR 具有较高的诊断性能,预测基于导丝的 IMR 的汇总敏感性为 0.81(95%置信区间:0.76,0.85),特异性为 0.80(0.72,0.86),AUC 为 0.86(0.82,0.88),无论患者的表现如何,结果均相似。当将心肌梗死患者的高 versus 低 angio-IMR 与临床结局进行比较时,高 angio-IMR 预测了主要不良心脏事件(MACE)的风险增加。
我们的研究发现,冠状动脉 angio-IMR 具有较高的诊断性能以及预测 MACE 的预后价值,支持其在临床实践中的应用。